De l’administration des prix à la régulation du marché : enjeux et modalités de la fixation des prix des médicaments en France depuis 1948

Abstract : This article studies the evolution of drug pricing by the French State since 1948. While the objectives of this policy have remained the same for 70 years — ensuring patients’ access to quality treatment, without over-burdening the budget of the Assurance maladie [health Insurance system] or compromising industrial development — its practical modalities have considerably evolved, moving from a State-based unilateral price-fixing scheme to a co-regulation of the drugs market with pharmaceutical companies. This transformation has led civil servants of the State and of the Assurance Maladie (the Economic Committee for Health Products) to deal with a growing number of players — pharmaceutical companies, independent experts, and health professionals — as well as with policies practiced in other countries. However, this has not led to a reduction in the state’s activity: on the contrary, the scope of regulation has extended to all actors and mechanisms determining the expenditure for reimbursed medicines.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01929612
Contributor : Spire Sciences Po Institutional Repository <>
Submitted on : Wednesday, November 21, 2018 - 12:16:50 PM
Last modification on : Tuesday, January 28, 2020 - 5:12:13 PM

Identifiers

Collections

Citation

Cyril Benoît, Etienne Nouguez. De l’administration des prix à la régulation du marché : enjeux et modalités de la fixation des prix des médicaments en France depuis 1948. Revue française des affaires sociales, 2018, pp.91 - 109. ⟨hal-01929612⟩

Share

Metrics

Record views

30